Related Experiment Videos
Human malignant melanoma cells: morphological and immunological variations
Neoplasma
|January 1, 1977
Summary
Researchers identified two distinct patterns of human malignant melanoma cell growth in vitro. Post-surgery melanoma patient sera showed significant cytotoxic activity, and isolated glycoproteins stimulated lymphocytes from these patients, indicating potential therapeutic targets.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Human malignant melanoma cells exhibit distinct in vitro growth patterns.
- Cytotoxic activity in patient sera and cellular responses to tumor-derived factors are crucial in cancer research.
Purpose of the Study:
- To investigate the cytotoxic activity of antisera raised against two distinct malignant melanoma cell types.
- To assess the cytotoxic activity of serum from melanoma patients post-surgery.
- To analyze the immunomodulatory effects of melanoma-derived glycoproteins on lymphocytes.
Main Methods:
- In vitro cell culture of malignant melanoma cells.
- Generation of rabbit antisera against melanoma cell types.
- Assessment of antiserum and patient serum cytotoxic activity against various cell lines.
- Isolation and characterization of glycoprotein fractions from melanoma cells.
- Measurement of 14C-2-thymidine uptake and DNA-polymerase activity in lymphocytes.
Main Results:
- Rabbit antisera exhibited cytotoxic activity against malignant melanoma cells.
- Melanoma patient sera, particularly 30 days post-surgery, displayed significant cytotoxic activity, classifying into two groups.
- Isolated glycoproteins stimulated lymphocyte proliferation (14C-2-thymidine uptake) and DNA-polymerase activity in peripheral blood lymphocytes from post-surgery melanoma patients.
- These glycoproteins had no effect on lymphocytes from normal donors.
Conclusions:
- Distinct malignant melanoma cell types can be differentiated by their growth patterns and antigenic properties.
- Post-surgical serum from melanoma patients contains cytotoxic factors that can be categorized.
- Melanoma-derived glycoproteins possess immunomodulatory properties, stimulating lymphocytes from cancer patients, suggesting a potential role in cancer immunotherapy.